BioSpace News Archive

Umoja Biopharma, Inc. and IASO Biotherapeutics announced today that they have entered into a research agreement to evaluate Umoja’s iCIL platform with IASO’s best-in-class CARs,

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Executive Management Team will present at the 34th Annual Piper Sandler Healthcare Conference on Thursday, December 1, 2022, at 2:00 p.m. Eastern Time.

Citius Pharmaceuticals, Inc. today announced that the Company has been selected to participate in New Jersey’s Technology Business Tax Certificate Transfer (NOL) Program, more commonly known as the Net Operating Loss (NOL) Program, and will receive $3.6 million in non-dilutive capital through the New Jersey Economic Development Authority (NJEDA). Citius expects to receive the funds by late 2022 or early 2023.

EmbarkNeuro today announced that the first patient has been dosed in its Phase 2 trial of ANC-501, a first-in-class vasopressin 1b (V1b) receptor antagonist for the treatment of major depressive disorder (MDD).

BioLife Solutions, Inc., a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy and the broader biopharma markets, provided an update on the expansion of its intellectual property estate.

Graphite Bio, Inc. today announced that members of the management team will participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Conference on Thursday, Dec. 1, 2022, at 11:45 a.m. ET.

Flare Therapeutics today announced that Daphne Karydas, Chief Operating Officer and Chief Financial Officer of Flare Therapeutics, will present a company overview at 9:30 a.m. ET on Thursday, December 1, 2022 at the Piper Sandler 34th Annual Healthcare Conference being held in New York, NY.

Healiva ®, a patient-centric company delivering life-enhancing precision medicine for patients with chronic and acute wounds, announced today the acquisition of critical manufacturing assets from B. Braun Medical AG Switzerland, an affiliate of German medical and pharmaceutical device company, B. Braun SE.

Thermo Fisher Scientific Inc. will present at the Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 10:30 a.m. (EST).

Azura Ophthalmics Ltd. today announced that members of management will present at BTIG’s Ophthalmology Day 2022, being held on November 29, and at the Piper Sandler 34th Annual Healthcare Conference, being held from November 29 through December 1.